Circulating CC16, immune response to Mycoplasma pneumoniae and lung function: a population-based, multi-cohort study
- 14 March 2025
- journal article
- Published by Elsevier in Respiratory Medicine
- Vol. 240, 108044
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (P30CA118100)
- National Institutes of Health (T32HL007249)
- National Institutes of Health (AI135108)
- National Institutes of Health (HL142769)
This publication has 31 references indexed in Scilit:
- Lung-function trajectories: relevance and implementation in clinical practiceThe Lancet, 2024
- Club cell secretory protein and lung function in children with cystic fibrosisJournal of Cystic Fibrosis, 2022
- Mycoplasma pneumoniae infection and risk of childhood asthma: A systematic review and meta-analysisMicrobial Pathogenesis, 2021
- Lung function trajectories from pre-school age to adulthood and their associations with early life factors: a retrospective analysis of three population-based birth cohort studiesThe Lancet Respiratory Medicine, 2018
- Club cell secretory protein in serum and bronchoalveolar lavage of patients with asthmaJournal of Allergy and Clinical Immunology, 2016
- Incident asthma and Mycoplasma pneumoniae: A nationwide cohort studyJournal of Allergy and Clinical Immunology, 2016
- Relation between circulating CC16 concentrations, lung function, and development of chronic obstructive pulmonary disease across the lifespan: a prospective studyThe Lancet Respiratory Medicine, 2015
- Serum levels of Clara cell secretory protein, asthma, and lung function in the adult general populationJournal of Allergy and Clinical Immunology, 2013
- Cigarette Smoking and InfectionArchives of internal medicine (1960), 2004
- Role of atypical bacterial infection of the lung in predisposition/protection of asthmaPharmacology & Therapeutics, 2004